P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2023-04, Vol.62 (Supplement_2)
Main Authors: Alten, Rieke, Burmester, Gerd R, Matucci-Cerinic, Marco, Ostor, Andrew, Zaremba-Pechmann, Liliana, Treuer, Tamas, Ng, Khai Jing, Gerwien, Jens, Gibson, Kathryn A, Fautrel, Bruno, Sheeran, Thomas
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1982-c9bf8dcdca7e0bbf7665e80ec54ae895a2b4ae7e7ef7d2aa0e20d61fc18248943
cites
container_end_page
container_issue Supplement_2
container_start_page
container_title Rheumatology (Oxford, England)
container_volume 62
creator Alten, Rieke
Burmester, Gerd R
Matucci-Cerinic, Marco
Ostor, Andrew
Zaremba-Pechmann, Liliana
Treuer, Tamas
Ng, Khai Jing
Gerwien, Jens
Gibson, Kathryn A
Fautrel, Bruno
Sheeran, Thomas
description
doi_str_mv 10.1093/rheumatology/kead104.172
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_rheumatology_kead104_172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_rheumatology_kead104_172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1982-c9bf8dcdca7e0bbf7665e80ec54ae895a2b4ae7e7ef7d2aa0e20d61fc18248943</originalsourceid><addsrcrecordid>eNpNUFtOwzAQjBBIlMId9gBNaztv_kpbHlKrIijf0caxiSGPynaK-ofEZTgXJyHQCKH92JFmd2Y0jgOUjClJvIkuRFuhbcrmeT95FZhT4o9pxI6cAfVD5hLPY8d_mPmnzpkxL4SQgHrxwPm8px79ev_YqEqAbWCuDG9qq-oWrWpqwDqHhZSCW7UTtTAG3pQt4Aq14qo7UxmoGh76ECqHqbaF7hhzCZS5q06rgEWrm63AGuZoEaRuKkBYtWX3_-uC5QjudWO2B5sRrDMj9K7n4NG2-f7cOZFYGnHR76HzdL3YzG7d5frmbjZdupwmMXN5ksk45znHSJAsk1EYBiImggc-ijgJkGUdiLqRUc4QiWAkD6nkNGZ-nPje0IkPurwLZLSQ6VarCvU-pST9aTz933jaN552jXvfsYt_3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>Alten, Rieke ; Burmester, Gerd R ; Matucci-Cerinic, Marco ; Ostor, Andrew ; Zaremba-Pechmann, Liliana ; Treuer, Tamas ; Ng, Khai Jing ; Gerwien, Jens ; Gibson, Kathryn A ; Fautrel, Bruno ; Sheeran, Thomas</creator><creatorcontrib>Alten, Rieke ; Burmester, Gerd R ; Matucci-Cerinic, Marco ; Ostor, Andrew ; Zaremba-Pechmann, Liliana ; Treuer, Tamas ; Ng, Khai Jing ; Gerwien, Jens ; Gibson, Kathryn A ; Fautrel, Bruno ; Sheeran, Thomas ; Non-Author Presenter</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kead104.172</identifier><language>eng</language><ispartof>Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1982-c9bf8dcdca7e0bbf7665e80ec54ae895a2b4ae7e7ef7d2aa0e20d61fc18248943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Alten, Rieke</creatorcontrib><creatorcontrib>Burmester, Gerd R</creatorcontrib><creatorcontrib>Matucci-Cerinic, Marco</creatorcontrib><creatorcontrib>Ostor, Andrew</creatorcontrib><creatorcontrib>Zaremba-Pechmann, Liliana</creatorcontrib><creatorcontrib>Treuer, Tamas</creatorcontrib><creatorcontrib>Ng, Khai Jing</creatorcontrib><creatorcontrib>Gerwien, Jens</creatorcontrib><creatorcontrib>Gibson, Kathryn A</creatorcontrib><creatorcontrib>Fautrel, Bruno</creatorcontrib><creatorcontrib>Sheeran, Thomas</creatorcontrib><creatorcontrib>Non-Author Presenter</creatorcontrib><title>P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study</title><title>Rheumatology (Oxford, England)</title><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNUFtOwzAQjBBIlMId9gBNaztv_kpbHlKrIijf0caxiSGPynaK-ofEZTgXJyHQCKH92JFmd2Y0jgOUjClJvIkuRFuhbcrmeT95FZhT4o9pxI6cAfVD5hLPY8d_mPmnzpkxL4SQgHrxwPm8px79ev_YqEqAbWCuDG9qq-oWrWpqwDqHhZSCW7UTtTAG3pQt4Aq14qo7UxmoGh76ECqHqbaF7hhzCZS5q06rgEWrm63AGuZoEaRuKkBYtWX3_-uC5QjudWO2B5sRrDMj9K7n4NG2-f7cOZFYGnHR76HzdL3YzG7d5frmbjZdupwmMXN5ksk45znHSJAsk1EYBiImggc-ijgJkGUdiLqRUc4QiWAkD6nkNGZ-nPje0IkPurwLZLSQ6VarCvU-pST9aTz933jaN552jXvfsYt_3w</recordid><startdate>20230424</startdate><enddate>20230424</enddate><creator>Alten, Rieke</creator><creator>Burmester, Gerd R</creator><creator>Matucci-Cerinic, Marco</creator><creator>Ostor, Andrew</creator><creator>Zaremba-Pechmann, Liliana</creator><creator>Treuer, Tamas</creator><creator>Ng, Khai Jing</creator><creator>Gerwien, Jens</creator><creator>Gibson, Kathryn A</creator><creator>Fautrel, Bruno</creator><creator>Sheeran, Thomas</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230424</creationdate><title>P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study</title><author>Alten, Rieke ; Burmester, Gerd R ; Matucci-Cerinic, Marco ; Ostor, Andrew ; Zaremba-Pechmann, Liliana ; Treuer, Tamas ; Ng, Khai Jing ; Gerwien, Jens ; Gibson, Kathryn A ; Fautrel, Bruno ; Sheeran, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1982-c9bf8dcdca7e0bbf7665e80ec54ae895a2b4ae7e7ef7d2aa0e20d61fc18248943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alten, Rieke</creatorcontrib><creatorcontrib>Burmester, Gerd R</creatorcontrib><creatorcontrib>Matucci-Cerinic, Marco</creatorcontrib><creatorcontrib>Ostor, Andrew</creatorcontrib><creatorcontrib>Zaremba-Pechmann, Liliana</creatorcontrib><creatorcontrib>Treuer, Tamas</creatorcontrib><creatorcontrib>Ng, Khai Jing</creatorcontrib><creatorcontrib>Gerwien, Jens</creatorcontrib><creatorcontrib>Gibson, Kathryn A</creatorcontrib><creatorcontrib>Fautrel, Bruno</creatorcontrib><creatorcontrib>Sheeran, Thomas</creatorcontrib><creatorcontrib>Non-Author Presenter</creatorcontrib><collection>CrossRef</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alten, Rieke</au><au>Burmester, Gerd R</au><au>Matucci-Cerinic, Marco</au><au>Ostor, Andrew</au><au>Zaremba-Pechmann, Liliana</au><au>Treuer, Tamas</au><au>Ng, Khai Jing</au><au>Gerwien, Jens</au><au>Gibson, Kathryn A</au><au>Fautrel, Bruno</au><au>Sheeran, Thomas</au><aucorp>Non-Author Presenter</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><date>2023-04-24</date><risdate>2023</risdate><volume>62</volume><issue>Supplement_2</issue><issn>1462-0324</issn><eissn>1462-0332</eissn><doi>10.1093/rheumatology/kead104.172</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)
issn 1462-0324
1462-0332
language eng
recordid cdi_crossref_primary_10_1093_rheumatology_kead104_172
source Oxford Journals Online; Alma/SFX Local Collection
title P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A24%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P131%E2%80%83Time%20to%20Discontinuation%20and%20Effectiveness%20with%20Baricitinib%20in%20Rheumatoid%20Arthritis:%2012-Month%20European%20Data%20from%20a%20Multinational,%20Prospective,%20Observational%20Study&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Alten,%20Rieke&rft.aucorp=Non-Author%20Presenter&rft.date=2023-04-24&rft.volume=62&rft.issue=Supplement_2&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kead104.172&rft_dat=%3Ccrossref%3E10_1093_rheumatology_kead104_172%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1982-c9bf8dcdca7e0bbf7665e80ec54ae895a2b4ae7e7ef7d2aa0e20d61fc18248943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true